Marchex-B

Q2 FY2026 EarningsQ2 FY26 revenue of $11.0M was slightly below the $11.2M consensus, while GAAP EPS of ($0.01) and adjusted EPS of $0.00 both missed expectations of $0.01 and $0.02 respectively. Despite the headline misses, Adjusted EBITDA before acquisition costs reached $1.7M, showing operational leverage. Post-acquisition pro forma guidance for Q3 FY26 of $16.0M–$16.5M suggests significant scale expansion following the Archenia deal, outperforming the standalone trajectory.